GRTX galeratx.com: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
The quote characteristics for Galera Therapeutics (GRTX) on GURU.Markets based on the separate_ev_ebitda metric are . Galera Therapeutics (GRTX) is implementing digital systems for remote monitoring of trial participants to eliminate manual data entry. The firm previously developed radiation protection agents based on mimetics. Currently, due to FDA prohibitions, the company is shutting down development and distributing remaining cash funds to shareholders.
פילוחי מדדים ואנליטיקה של חברת Galera (GRTX)
Galera Therapeutics (GRTX) is in a critical state due to failed clinical trials and a loss of confidence in management. This indicator compares the total enterprise value, including debt, with its operating profit, revealing the asset's real value regardless of financial manipulations. By analyzing the Galera Therapeutics (GRTX) EV/EBITDA multiple chart, investors determine whether the current low valuation is a sign of undervaluation or a precursor to the biotech's imminent bankruptcy.
